Security
Adhera Therapeutics Inc Common Stock · ATRX
ATRXOTCCommon stockHistorical · closed Oct 6, 2022CIK 737207Updated Nov 16, 2026
Name history
Marina Biotech, Inc. · through Oct 9, 2018MDRNA, Inc. · through Jul 21, 2010NASTECH PHARMACEUTICAL CO INC · through Jun 9, 2008
Current security for this SEC filerATRX · OTC
ATRX price & chart
Historical security
This listing closed Oct 6, 2022. Live provider charts are shown only for current listings.
Current security: ATRX
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2022 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2023 | Q3 2022 | Q3 2021 | Q2 2023 | Q2 2022 | Q2 2021 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 44,074Source | 256,000Source | 151,000Source | 82,000Source | 976,000Source | 42,000Source | 104,000Source | 170,000Source | 79,000Source | 196,000Source | 1,000Source | 420,000Source |
| Property, Plant and Equipment, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 133,000Source | 151,000Source | — | 849,000Source | 42,000Source | — | 40,000Source | 32,000Source | 76,000Source | — | — |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Inventory, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Assets, CurrentUSD | 44,074Source | 256,000Source | 151,000Source | 82,000Source | 976,000Source | 42,000Source | 104,000Source | 170,000Source | 79,000Source | 196,000Source | 1,000Source | 420,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | — | — | — | — | — | — | — | — | — | — | — | 370,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 26,359,515Source | 22,063,000Source | 20,390,000Source | 22,869,000Source | 20,971,000Source | 16,382,000Source | 23,197,000Source | 25,668,000Source | 22,265,000Source | 25,302,000Source | — | — |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 31,014Source | 18,000Source | 87,000Source | 23,000Source | 379,000Source | 71,000Source | 19,000Source | 105,000Source | 19,000Source | 102,000Source | 67,000Source | 65,000Source |
| Additional Paid in CapitalUSD | 33,636,179Source | 33,547,000Source | 30,647,000Source | 33,610,000Source | 33,186,000Source | 30,417,000Source | 33,553,000Source | 27,852,000Source | 33,548,000Source | 27,809,000Source | 29,772,000Source | 29,375,000Source |
| Retained Earnings (Accumulated Deficit)USD | -59,980,637Source | -55,370,000Source | -50,973,000Source | -56,418,000Source | -53,558,000Source | -46,828,000Source | -56,663,000Source | -53,455,000Source | -55,751,000Source | -53,017,000Source | -44,612,000Source | -39,327,000Source |
| Stockholders' Equity Attributable to ParentUSD | -26,315,441Source | -21,805,438Source | -20,239,000Source | -22,787,000Source | -19,995,000Source | -16,340,000Source | -23,093,000Source | -25,498,000Source | -22,186,000Source | -25,106,000Source | -14,773,000Source | -9,887,000Source |
| Liabilities and EquityUSD | 44,074Source | 256,000Source | 151,000Source | 82,000Source | 976,000Source | 42,000Source | 104,000Source | 170,000Source | 79,000Source | 196,000Source | 1,000Source | 420,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 26,359,515Source | 22,063,000Source | 20,390,000Source | 22,869,000Source | 20,971,000Source | 16,382,000Source | 23,197,000Source | 25,668,000Source | 22,265,000Source | 25,302,000Source | 14,774,000Source | 10,307,000Source |
| Accounts Payable, CurrentUSD | 2,351,653Source | 2,312,000Source | 2,287,000Source | 2,318,000Source | 2,339,000Source | 2,280,000Source | 2,410,000Source | 2,287,000Source | 2,397,000Source | 2,309,000Source | 2,257,000Source | 1,403,000Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | 5,545,905Source | 4,041,000Source | 2,874,000Source | 5,139,000Source | 3,697,000Source | 2,671,000Source | 4,725,000Source | 3,467,000Source | 4,373,000Source | 3,110,000Source | 2,112,000Source | 1,005,000Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Dividends Payable, CurrentUSD | 578,333Source | 453,000Source | 5,211,000Source | 551,000Source | 445,000Source | 4,830,000Source | 525,000Source | 5,841,000Source | 498,000Source | 5,477,000Source | 4,083,000Source | 2,565,000Source |
cash flow · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | -6,400,000Source | — | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | 143,238Source | 154,161Source | — | 0Source | — | — | — | — | 8,000Source | 765,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | — | — | — | — | — | -16,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | — | — | — | — | — | 240,000Source |
| Increase (Decrease) in Accounts PayableUSD | — | — | — | — | — | — | 8,000Source | 8,000Source | 68,000Source | 94,000Source | 854,000Source | 1,133,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -310,000Source | -216,000Source | -1,415,000Source | -665,000Source | -588,000Source | -8,738,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | — | — | 2,000Source | — | — | 0Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 347,000Source | 180,000Source | 1,371,000Source | 739,000Source | 539,000Source | 4,870,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 37,000Source | -36,000Source | -44,000Source | 74,000Source | -49,000Source | -3,868,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | — | — | — | — | — | — | — | — | 1,000Source | — |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 4,000Source | — | 94,000Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 765,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | — | — | 400,000Source | 360,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | 245,839Source | 777,082Source | 392,000Source | 313,000Source | 608,000Source | 175,000Source | 1,809,000Source | 398,000Source | — | — |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | 70,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | — | — | — | 12,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | -2,673,966Source | -253,723Source | — | — | 717,000Source | 667,000Source | 2,324,000Source | -4,103,000Source | — | — |
| Dividends Payable, CurrentUSD | — | — | 578,333Source | 453,000Source | 551,000Source | 445,000Source | 525,000Source | 5,841,000Source | 498,000Source | 5,477,000Source | 4,083,000Source | 2,565,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | — | — | — | — | — | -60,000Source |
| Gain (Loss) on Sale of Assets and Asset Impairment ChargesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Gain (Loss) on Termination of LeaseUSD | — | — | — | — | — | — | — | — | — | — | — | 7,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 12,671Source | 92,068Source | 36,000Source | 210,000Source | 39,000Source | 5,000Source | 333,000Source | -141,000Source | — | 0Source |
| General and Administrative ExpenseUSD | — | — | 42,992Source | 224,243Source | 296,000Source | 449,000Source | 353,000Source | 260,000Source | 1,618,000Source | 657,000Source | 1,198,000Source | 4,713,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | — | 1,116,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 300,000Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | — | — | — | — | — | — | — | — | — | — | — | 338,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,535,815Source | -1,803,352Source | 271,000Source | 99,000Source | -886,000Source | -74,000Source | -2,114,000Source | -6,351,000Source | -3,766,000Source | -11,978,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -3,562,735Source | -1,812,058Source | 245,000Source | -307,000Source | -912,000Source | -438,000Source | -2,734,000Source | -8,405,000Source | -5,306,000Source | -13,479,000Source |
| Nonoperating Income (Expense)USD | — | — | -3,266,318Source | -1,255,782Source | 567,000Source | 548,000Source | -533,000Source | 186,000Source | -496,000Source | -5,677,000Source | — | — |
| Operating ExpensesUSD | — | — | 269,497Source | 547,570Source | 296,000Source | 449,000Source | 353,000Source | 260,000Source | 1,618,000Source | 674,000Source | 2,037,000Source | 11,159,000Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 707,000Source |
income statement · annual statements
| Line item | Q4 2022 | Q4 2021 | Q3 2023 | Q3 2022 | Q2 2023 | Q2 2022 | Q1 2023 | Q1 2022 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | — | — | — | — | — | — | — | — | — | 252,000Source |
| Cost of RevenueUSD | — | — | — | — | — | — | — | — | — | — | — | 409,000Source |
| Operating Income (Loss)USD | — | — | -269,497Source | -547,570Source | -296,000Source | -449,000Source | -353,000Source | -260,000Source | -1,618,000Source | -674,000Source | -2,037,000Source | -11,316,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | -533,000Source | -74,000Source | -2,114,000Source | -6,351,000Source | -3,766,000Source | -11,978,000Source |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,535,815Source | -1,803,352Source | 271,000Source | 99,000Source | -886,000Source | -74,000Source | -2,114,000Source | -6,351,000Source | -3,766,000Source | -11,978,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.83Source | -0.57Source | 0.07Source | -0.27Source | -0.29Source | -0.51Source | -1.18Source | — | — | -1.24Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 4,303,866Source | 3,160,877Source | 3,462,539Source | 1,140,083Source | 3,176,952Source | 858,959Source | 2,307,534Source | — | — | 10,840,870Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | 70,000Source |
| General and Administrative ExpenseUSD | — | — | 42,992Source | 224,243Source | 296,000Source | 449,000Source | 353,000Source | 260,000Source | 1,618,000Source | 657,000Source | 1,198,000Source | 4,713,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 300,000Source |
| Gross ProfitUSD | — | — | — | — | — | — | — | — | — | — | — | -157,000Source |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 682,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -3,562,735Source | -1,812,058Source | 245,000Source | -307,000Source | -912,000Source | -438,000Source | -2,734,000Source | -8,405,000Source | -5,306,000Source | -13,479,000Source |
| Nonoperating Income (Expense)USD | — | — | -3,266,318Source | -1,255,782Source | 567,000Source | 548,000Source | -533,000Source | 186,000Source | -496,000Source | -5,677,000Source | — | — |
| Operating ExpensesUSD | — | — | 269,497Source | 547,570Source | 296,000Source | 449,000Source | 353,000Source | 260,000Source | 1,618,000Source | 674,000Source | 2,037,000Source | 11,159,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | 26,920Source | 8,706Source | 26,000Source | 406,000Source | 26,000Source | 364,000Source | 620,000Source | 2,054,000Source | 1,540,000Source | 1,501,000Source |
| Research and Development ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Selling and Marketing ExpenseUSD | — | — | — | — | — | — | — | — | — | 17,000Source | 839,000Source | 5,260,000Source |
| Earnings Per Share, Diluted | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | —Source | —Source | —Source | —Source | — | — | — | — | — | — |